You are here

Clinical Trials: Nervous System Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, December 13, 2016 - 12:00
Condition:   Autoimmune Encephalopathy
Intervention:   Drug: Vigabatrin 500 MG
Sponsor:   Seoul National University Hospital
Recruiting - verified December 2016
Posted: Monday, December 5, 2016 - 12:00
Conditions:   RSD (Reflex Sympathetic Dystrophy);   CRPS - Complex Regional Pain Syndrome Type I;   Fibromyalgia
Interventions:   Procedure: Lipoaspiration;   Procedure: ADcSVF isolation;   Procedure: Normal Saline IV
Sponsor:   Healeon Medical Inc
Recruiting - verified December 2016
Posted: Thursday, December 1, 2016 - 12:00
Condition:   Spinal Cord Injuries
Intervention:   Biological: Autologous Mesenchymal Stem Cells
Sponsor:   University of Jordan
Recruiting - verified December 2016
Posted: Thursday, October 20, 2016 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: Stem cell (HPC) implantation
Sponsor:   Cedars-Sinai Medical Center
Not yet recruiting - verified October 2016
Posted: Thursday, October 20, 2016 - 12:00
Conditions:   Corneal Injuries;   Corneal Burns;   Corneal Scars and Opacities
Intervention:   Biological: Ex-vivo cultivated limbal stem cell pool
Sponsor:   L.V. Prasad Eye Institute
Recruiting - verified October 2016
Posted: Sunday, October 2, 2016 - 12:00
Condition:   Delayed Encephalopathy After Carbon Monoxide Poisoning
Interventions:   Biological: Human cord blood mononuclear cell;   Other: hyperbaric oxygen
Sponsor:   Liaocheng People's Hospital
Recruiting - verified October 2016
Posted: Monday, September 26, 2016 - 12:00
Condition:   AMYOTROPHIC LATERAL SCLEROSIS
Intervention:   Other: Two intrathecal MSC injections
Sponsors:   University of Sao Paulo General Hospital;   Pontifícia Universidade Católica do Paraná
Recruiting - verified September 2016
Posted: Tuesday, September 20, 2016 - 12:00
Condition:   Acute Traumatic Spinal Cord Injury
Interventions:   Drug: FAB117-HC;   Other: Control group;   Drug: FAB117-HC
Sponsors:   Ferrer Internacional S.A.;   Histocell S.L.
Not yet recruiting - verified September 2016
Posted: Friday, September 9, 2016 - 12:00
Condition:   Epilepsy
Intervention:   Drug: Omega-3
Sponsor:   Seoul National University Hospital
Recruiting - verified September 2016
Posted: Friday, September 2, 2016 - 12:00
Condition:   Alzheimer's Disease
Interventions:   Biological: CB-AC-02;   Biological: Placebo
Sponsor:   CHABiotech CO., Ltd
Not yet recruiting - verified September 2016

Pages